Come up with a name for your new list and we'll add to it:
Synapsin Pharmaceuticals raised a round of funding on , . Investors include
USC Columbia Technology Incubator.
SYNAPSIN is developing therapeutic strategies for the treatmentand prevention ofneurodegenerative disorders such as Alzheimer's disease (AD),Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), a…